1.Serum Concentrations of Insulin, Ghrelin, Adiponectin, Leptin, Leptin Receptor and Lipocalin-2 in Children with Celiac Disease Who Do and Do Not Adhere to a Gluten-Free Diet.
Roman M JANAS ; Anna RYBAK ; Aldona WIERZBICKA-RUCIŃSKA ; Piotr SOCHA ; Rafał ŚNITKO ; Anna SZAFLARSKA-POPŁAWSKA ; Anna STOLARCZYK ; Beata ORALEWSKA ; Elżbieta CYTRA-JAROCKA ; Barbara IWAŃCZAK ; Urszula GRZYBOWSKA-CHLEBOWCZYK ; Wojciech CICHY ; Grażyna CZAJA-BULSA ; Jerzy SOCHA
Gut and Liver 2016;10(4):587-594
BACKGROUND/AIMS: The roles of the many bioactive peptides in the pathogenesis of celiac disease remain unclear. To evaluate the serum concentrations of insulin, ghrelin, adiponectin, leptin, leptin receptor, and lipocalin-2 in children with celiac disease who do and do not adhere to a gluten-free diet (GFD, intermittent adherence). METHODS: Prepubertal, pubertal, and adolescent celiac children were included in this study (74 girls and 53 boys on a GFD and 80 girls and 40 boys off of a GFD). RESULTS: Insulin levels in prepubertal (9.01±4.43 μIU/mL), pubertal (10.3±3.62 μIU/mL), and adolescent (10.8±4.73 μIU/mL) girls were higher than those in boys (5.88±2.02, 8.81±2.88, and 8.81±2.26 μIU/mL, respectively) and were neither age-dependent nor influenced by a GFD. Prepubertal children off of a GFD exhibited higher ghrelin levels than prepubertal children on a GFD. Adiponectin levels were not age-, sex- nor GFD-dependent. Adherence to a GFD had no effect on the expression of leptin, leptin receptor, and lipocalin-2. CONCLUSIONS: Adherence to a GFD had no influence on the adiponectin, leptin, leptin receptor, and lipocalin-2 concentrations in celiac children, but a GFD decreased highly elevated ghrelin levels in prepubertal children. Further studies are required to determine whether increased insulin concentrations in girls with celiac disease is suggestive of an increased risk for hyperinsulinemia.
Adiponectin*
;
Adolescent
;
Celiac Disease*
;
Child*
;
Diet, Gluten-Free*
;
Female
;
Ghrelin*
;
Humans
;
Hyperinsulinism
;
Insulin*
;
Leptin*
;
Peptides
;
Receptors, Leptin*
2.Novel opioid-neurotensin-based hybrid peptide with spinal long-lasting antinociceptive activity and a propensity to delay tolerance development.
Karolina FRĄCZEK ; Mattia FERRAIOLO ; Emmanuel HERMANS ; Magdalena BUJALSKA-ZADROZNY ; Kaja KASARELLO ; Anna ERDEI ; Kamila KULIK ; Agnieszka KOWALCZYK ; Piotr WOJCIECHOWSKI ; Dorota SULEJCZAK ; Piotr SOSNOWSKI ; Sebastian GRANICA ; Sandor BENYHE ; Katarzyna KACZYNSKA ; Lukasz NAGRABA ; Artur STOLARCZYK ; Agnieszka CUDNOCH-JEDRZEJEWSKA ; Patrycja KLECZKOWSKA
Acta Pharmaceutica Sinica B 2020;10(8):1440-1452
The behavioral responses exerted by spinal administration of the opioid-neurotensin hybrid peptide, PK23, were studied in adult male rats. The antinociceptive effect upon exposure to a thermal stimulus, as well as tolerance development, was assessed in an acute pain model. The PK23 chimera at a dose of 10 nmol/rat produced a potent pain-relieving effect, especially after its intrathecal administration. Compared with intrathecal morphine, this novel compound was found to possess a favourable side effect profile characterized by a reduced scratch reflex, delayed development of analgesic tolerance or an absence of motor impairments when given in the same manner, though some animals died following barrel rotation as a result of its i.c.v. administration (in particular at doses higher than 10 nmol/rat). Nonetheless, these results suggest the potential use of hybrid compounds encompassing both opioid and neurotensin structural fragments in pain management. This highlights the enormous potential of synthetic neurotensin analogues as promising future analgesics.